Clinical Trial Update: Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating intra-arterial Y-90 TheraSpheres for hepatic metastases from solid tumors has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Metastases

Drugs mentioned

• TheraSpheres (yttrium-90 glass microspheres)

Snippet

Sponsor: Yale University | Conditions: Liver Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2017-08-28